Consequently, in the TLR/NF-κB inhibition group, the inflammatory response in adipocytes was significantly suppressed, with reduced expression levels of TLR-4 and NF-κB-related proteins, thereby decreasing the production of inflammatory factors, which may help alleviate obesity-related chronic inflammation. The gene discussed is TLR4; the disease is obesity disorder.